Elisabetta Cariani
Overview
Explore the profile of Elisabetta Cariani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
327
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
High CD49a+ NK cell infiltrate is associated with poor clinical outcomes in Hepatocellular Carcinoma
Zecca A, Barili V, Boni C, Fisicaro P, Vecchi A, Rossi M, et al.
Heliyon
. 2023 Dec;
9(12):e22680.
PMID: 38107324
NK cells infiltrating Hepatocellular Carcinoma (HCC) may express residency markers such as Integrin Subunit Alpha 1 (CD49a) that have been associated with nurturing functions in the decidua, and characterized by...
2.
Zecca A, Barili V, Olivani A, Biasini E, Boni C, Fisicaro P, et al.
Front Immunol
. 2022 Jun;
13:875072.
PMID: 35677052
Natural killer (NK) cells may become functionally exhausted entering hepatocellular carcinoma (HCC), and this has been associated with tumor progression and poor clinical outcome. Hypoxia, low nutrients, immunosuppressive cells, and...
3.
Zecca A, Barili V, Rizzo D, Olivani A, Biasini E, Laccabue D, et al.
Cells
. 2021 Apr;
10(3).
PMID: 33802077
Previous studies support the role of natural killer (NK) cells in controlling hepatocellular carcinoma (HCC) progression. However, ambiguity remains about the multiplicity and the role of different NK cell subsets,...
4.
Zecca A, Barili V, Canetti D, Regina V, Olivani A, Carone C, et al.
Cancer Immunol Immunother
. 2020 Apr;
69(8):1589-1603.
PMID: 32307580
Functional rescue of NK-cells in solid tumors represents a central aim for new immunotherapeutic strategies. We have conducted a genomic, phenotypic and functional analysis of circulating NK-cells from patients with...
5.
Pecoraro V, Banzi R, Cariani E, Chester J, Villa E, DAmico R, et al.
J Clin Exp Hepatol
. 2019 Sep;
9(4):522-538.
PMID: 31516269
Background: New direct-acting antiviral agents (DAAs) approved for the treatment of patients infected by Hepatitis C virus (HCV) are well tolerated and increase sustained virological response (SVR) rate. We summarize...
6.
Cariani E, Missale G
Liver Int
. 2019 Jul;
39(9):1608-1621.
PMID: 31314948
The development of immunotherapy for solid tumours has boosted interest in the contexture of tumour immune microenvironment (TIME). Several lines of evidence indicate that the interplay between tumour cells and...
7.
Veronesi A, Cariani E, Trenti T, Rota C
Alcohol Alcohol
. 2019 Jul;
54(5):510-515.
PMID: 31294769
Aims: Carbohydrate-deficient transferrin (CDT) is a marker of chronic alcohol abuse. Uninterpretable (atypical) CDT patterns have been detected by both capillary electrophoresis (CE) and HPLC. The aim of this study...
8.
Cammarata I, Martire C, Citro A, Raimondo D, Fruci D, Melaiu O, et al.
J Autoimmun
. 2019 Feb;
99:81-97.
PMID: 30777378
The mechanisms whereby autoreactive T cells escape peripheral tolerance establishing thus autoimmune diseases in humans remain an unresolved question. Here, we demonstrate that autoreactive polyfunctional CD8 T cells recognizing self-antigens...
9.
Carone C, Olivani A, Dalla Valle R, Manuguerra R, Silini E, Trenti T, et al.
Liver Cancer
. 2018 Oct;
7(3):277-294.
PMID: 30319985
Background: The antitumor immune response may play a major role in the clinical outcome of hepatocellular carcinoma (HCC). We characterized the liver immune microenvironment by direct hybridization of RNA extracted...
10.
Lelli N, Rizkallah R, Ferrari P, Pedretti S, Cariani E, Trenti T
Thromb Res
. 2016 Dec;
150:19-21.
PMID: 27992784
No abstract available.